effects of laparoscopic operation combined neoadjuvant chemotherapy on serum levels of cea, ca242, ca19-9, ca724, icam-1 and vcam-1 in patients with colorectal carcinoma

Clicks: 543
ID: 149706
2017
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #5 of 96 articles by views in journal of communications

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Objective: To observe the effects of neoadjuvant chemotherapy on the basis of laparoscopic operation on colorectal carcinoma patients, serum CEA, CA242, CA19-9, CA724, ICAM-1 and VCAM-1 levels. Methods: A total of 120 cases of colorectal carcinoma in our hospital from January 2012 to January 2015 were retrospectively analyzed and divided into control group and observation group, with each group of 60 patients. All patients were given laparoscopic operation, the patients in the observation group were given neoadjuvant chemotherapy (FOLFOX4 regimen) four cycles before laparoscopic surgery, fasting venous blood before and after treatment in the morning was taken and centrifuged, and the serum CA242, CA19-9, ICAM-1 and VCAM-1 levels were measured by ELISA, and the serum CEA levels were measured by MEIA, and the serum CA724 levels were measured by ECLI, and compared with those of the two groups. Results: (1) Before treatment, there was no statistically significant difference in the serum CEA, CA242, CA19-9 and CA724 levels between the two groups. After treatment, compared with the same group before treatment, the serum CEA, CA242, CA19-9 and CA724 levels of the two groups were significantly lower, and those levels of observation group were significantly better than the control group, there was significant difference between the two groups; (2) Before treatment, there was no statistically significant difference in the serum ICAM-1, VCAM-1 levels between the two groups. After treatment, compared with the same group before treatment, the serum ICAM-1, VCAM-1 levels of the two groups were significantly lower, and those levels of observation group were significantly better than the control group, there was significant difference between the two groups. Conclusion: The treatment of colorectal cancer patients with neoadjuvant chemotherapy combined with laparoscopic operation can effectively reduce serum CEA, CA242, CA19-9, CA724, ICAM-1 and VCAM-1 levels, indicating that the program can regulate cancer-related tumor markers and the expression of relative factors, to promote the recovery of patients with autoimmune system, ease the patient's condition, safe and reliable, worthy of clinical application.
Reference Key
xie2017journaleffects Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors ;Wen-Jie Xie;Yan-Hong Li;Chang-Fang Xie;Xin-Liang Liu;Shuai Zhang
Journal journal of communications
Year 2017
DOI
DOI not found
URL
http://www.hnykdxxb.com/PDF/201715/19.pdf
Keywords
neoadjuvant chemotherapy colorectal carcinoma serum parametermedicine

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.